How many 8-K filings has Lantern Pharma Inc. filed?

Lantern Pharma Inc. (LTRN) has 10 8-K (Current Event Report) filings on record, spanning Mar 2024 to Apr 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Lantern Pharma Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Lantern Pharma Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Lantern Pharma Inc. (LTRN) — 8-K Filings

All 8-K filings from Lantern Pharma Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

Lantern Pharma Files 8-K with Exhibits — Apr 10, 2026 Risk: medium
Lantern Pharma Inc. filed an 8-K on April 10, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The
Lantern Pharma Files 8-K on Financials — Nov 13, 2025 Risk: low
Lantern Pharma Inc. filed an 8-K on November 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD di
Lantern Pharma Inc. Files 8-K on Security Holder Vote — Sep 23, 2025 Risk: low
Lantern Pharma Inc. filed an 8-K on September 23, 2025, reporting on a matter submitted to a vote of security holders on September 19, 2025. The filing details
Lantern Pharma Inc. Files 8-K on Executive & Corporate Changes — Jul 29, 2025 Risk: medium
Lantern Pharma Inc. filed an 8-K on July 29, 2025, reporting events as of July 24, 2025. The filing covers the departure of directors or certain officers, elect
Lantern Pharma Files 8-K — Jul 3, 2025 Risk: low
Lantern Pharma Inc. filed an 8-K on July 3, 2025, reporting the entry into a material definitive agreement and filing financial statements and exhibits. The fil
Lantern Pharma Inc. Announces Board and Executive Compensation Changes — Jan 10, 2025 Risk: medium
Lantern Pharma Inc. announced on January 6, 2025, changes related to its board of directors and executive compensation. The filing indicates a departure of a di
8-K Filing — Nov 8, 2024
Lantern Pharma Inc. Files 8-K on Shareholder Vote — Jun 17, 2024 Risk: low
Lantern Pharma Inc. filed an 8-K on June 17, 2024, reporting on a matter submitted to a vote of security holders on June 13, 2024. The filing details the compan
Lantern Pharma Files 8-K with Corporate Updates — May 24, 2024 Risk: low
Lantern Pharma Inc. filed an 8-K on May 23, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, incorpo
Lantern Pharma Files 8-K on Financials — Mar 18, 2024 Risk: low
Lantern Pharma Inc. filed an 8-K on March 18, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD discl

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX